{{indexingdisabled}} Waters BD Biosciences Diagnostic Solutions Investor Presentation - Slide 17: Positions Flow Cytometry into Bioanalytical Characterization - FlowPaper FlipBook

Contents

  1. Slide 0: CREATING A Life Science Tools & Diagnostics Leader Focused on Regulated, High-Volume Testing
  2. Slide 1: Disclaimer
  3. Slide 2: Today’s Speakers
  4. Slide 3: A Strong, Shared Culture of Pioneering Science
  5. Slide 4: A Significant Value Creation Opportunity
  6. Slide 5: Large TAM w/ Growth Tied to Consistent Volume Expansion
  7. Slide 6: Unmatched Strategic Fit
  8. Slide 7: Increases Resilience & Growth Stability
  9. Slide 8: An Industry Leading Financial Outlook
  10. Slide 9: Transaction Expected to Yield Outstanding Financial Benefits
  11. Slide 10: BD Biosciences/Diagnostics is a Leader in Upstream & Clinical
  12. Slide 11: An Innovation Leader w/ Uniquely Differentiated Portfolio
  13. Slide 12: Attractive Financial Profile & Business Mix
  14. Slide 13: Waters is a Leader in Downstream, Regulated Applications
  15. Slide 14: Have Orchestrated Successful Transformation at Waters
  16. Slide 15: Strong Financial Profile & Operating Performance
  17. Slide 16: Accelerates Innovation Journey into BioSeparations
  18. Slide 17: Positions Flow Cytometry into Bioanalytical Characterization
  19. Slide 18: Scales Capabilities & Presence for Multiplex Diagnostics
  20. Slide 19: Substantial Financial Benefits Expected
  21. Slide 20: An Industry-Leading Financial Outlook
  22. Slide 21: Transaction Overview
  23. Slide 22: Summary: Two Businesses Uniquely Suited for Each Other
  24. Slide 23: CREATING A Life Science Tools & Diagnostics Leader
 
0 0